Evan Ingley

Associate Professor Evan Ingley is a faculty member at The University of Western Australia (School of Biomedical Sciences, Department of Pharmacology and Toxicology), and holds an adjunct position. He leads the Cell Signalling Group at the Perkins Institute, focusing on disease signaling networks in cancer and cardiovascular systems. His work spans bone cancer metastasis, cardiac ion channels, and erythropoiesis. He has secured grants from NHMRC, Cancer Council WA, and RPH MRF.

Education:

• PhD in Biochemistry and Molecular Biology (Australian National University, 1992)
• BSc(Hons) in Zoology (University of Canterbury, 1988)

Research Interests:

Current projects include:

• AFAP1L1 pathway in bone cancer metastasis
• Lyn/Src Family Kinase pathways in red blood cell longevity
• Personalized genomic medicine for sarcoma patients
• CRISPR/Cas9 editing of cardiac calcium channel variants

Grants & Collaborations:

• Led projects on osteosarcoma therapies (NHMRC-funded)
• Collaborations with Prof. Livia Hool on cardiac ion channels
• Co-investigator on grants totaling $15M+

Labs & Teams:

Leads the Cell Signalling Group, focusing on protein interactions, signaling networks, and translational cancer research.